Chris Sandburg
Recent Articles by Chris Sandburg
- Kempharm (KMPH) Shareholders Blinded by Short Term Greed Versus Solid Long Term Outlook
- CytoDyn Doubles Down on Revenue and EUA Strategy with Philippines Announcement
- COVID Stocks Popping in Sympathy with Positive Humanigen Top Line Data
- CytoDyn’s Smoking Gun For an Immediate EUA
- CytoDyn Saves Lives & Reduces COVID-19 Hospital Duration
- Leronlimab Trial Results All But Certain Pointing to Approval For CytoDyn
- Reddit Rebellion Targeting The Short Mafia Next
- RISE of the COVID-19 Therapeutics CytoDyn (OTCMKTS: CYDY) & Humanigen (NASDAQ:HGEN)
- CytoDyn (OTCMKTS: CYDY) Subtly Signals Pivot Into Philippines and Vaccine Market
- CytoDyn (OTCMKTS: CYDY) Accelerates Recruitment to 250 Patients in Pivotal COVID-19 Trial